1. Alternative Protein Scaffolds as Novel Biotherapeutics
   Michaela Gebauer et al, 2015, Biobetters CrossRef
2. Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules
   Kristina Westerlund et al, 2016, Molecular Pharmaceutics CrossRef